Cox6c integrates into cytochrome c oxidase (COX), the terminal complex of the mitochondrial electron transport chain. Its roles include:
OXPHOS Regulation: Facilitates electron transfer to oxygen, generating ATP .
Apoptosis: Released during mitochondrial membrane disruption, triggering intrinsic apoptosis .
Tissue-Specific Expression: High in heart, bladder, and colon; downregulated in COPD-associated muscle damage .
Transcriptional: Activated by PGC-1α via NRF-1 binding to its promoter .
Post-Translational: Inhibited by HIV-1 Tat protein and miR-4276 .
Splicing: DAZAP1 reduces pre-mRNA splicing efficiency, affecting mitochondrial energy .
Recombinant Cox6c is used in studies of mitochondrial dysfunction, disease models, and therapeutic development:
Differences in production systems and tags influence functionality and suitability for assays:
Cox6c serves as a biomarker and therapeutic target:
Mitochondrial Disorders: Altered expression linked to muscle wasting in COPD and diabetic nephropathy .
Infectious Diseases: Modulation in influenza infection suggests roles in apoptosis regulation .
Cancer: Upregulated in prostate cancer and uterine leiomyoma, driven by gene fusions (e.g., HMGIC-COX6C) .
Research priorities include: